Gambling and substance use disorders: Current status and future directions

American Journal on Addictions

Volumn 16, Issue 1, 2007, Pages 1-9

  Petry, Nancy M ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL FEATURE; DATA ANALYSIS; DISEASE CLASSIFICATION; DRUG DEPENDENCE; GENETIC ANALYSIS; HUMAN; MEDICAL RESEARCH; PATHOLOGICAL GAMBLING; PREVALENCE; REVIEW; SUBSTANCE ABUSE; TREATMENT OUTCOME;

BRAIN; COGNITION DISORDERS; FORECASTING; GAMBLING; HUMANS; IMPULSE CONTROL DISORDERS; PREVALENCE; PSYCHOLOGY; SUBSTANCE-RELATED DISORDERS;

EID: 33847413152     PISSN: 10550496     EISSN: 15210391     Source Type: Journal    
DOI: 10.1080/10550490601077668     Document Type: Review

References (107)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. Third edition. Washington, DC: American Psychiatric Association; 1980.
2. Shaffer HJ, Hall MN, Van der Bilt J. Estimating the prevalence of disordered gambling behavior in the United States and Canada: a research synthesis. Am J Public Health. 1999;89:1369-1376.
3. Kallick M, Suits D, Dielman T, Hybels J. A Survey of American Gambling Attitudes and Behavior. Research Report Series, Survey Research Center, Institute for Social Research. Ann Arbor: University of Michigan Press; 1979.
4. Gerstein DR, Volberg RA, Toce MT, et al. Gambling Impact and Behavior Study: Report to National Gambling Impact Study Commission. Chicago, Ill.: National Opinion Research Center; 1999.
5. Welte J, Barnes G, Wieczorek W, Tidwell MC, Parker J. Alcohol and gambling pathology among U.S. adults. Prevalence, demographic patterns and comorbidity. J Stud Alcohol. 2001;62:706-712.
6. Petry NM, Stinson FS, Grant BF. Comorbidity of DSM-IV pathological gambling and psychiatric disorders: Results from the National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry. 2005;66:564-574.
7. Lesieur HR, Blume SB. The South Oaks Gambling Screen (The SOGS): a new instrument for the identification of pathological gamblers. Am J Psychiatry. 1987;144:1184-1188.
8. Cox BJ, Enns MW, Michaud V. Comparisons between the South Oaks Gambling Screen and a DSM-IV-based interview in a community survey of problemgambling. Can J Psychiatry. 2004;49:258-264.
9. Cunningham-Williams RM, Cottler LB, Compton WM, Spitznagel EL, Ben-Abdallah A. Problem gambling and comorbid psychiatric and substance use disorders among drug users recruited from drug treatment and community settings. J Gambl Stud. 2000;16:347-376.
10. Langenbucher J, Bavly L, Labouvie E, Sanjuan PM, Martin CS. Clinical features of pathological gambling in an addictions treatment cohort. Psychol Addict Behav. 2001;15:77-79.
11. Toneatto T, Brennan J. Pathological gambling in treatment-seeking substance abusers. Addict Behav. 2002;27:465-469.
12. Feigelman W, Kleinman PH, Lesieur HR, Millman RB, Lesser ML. Pathological gambling among methadone patients. Drug Alcohol Depend. 1995;39:75-81.
13. Ledgerwood DM, Downey KK. Relationship between problem gambling and substance use in a methadone maintenance population. Addict Behav. 2002;27:483-491.
14. Spunt B, Lesieur H, Liberty HJ, Hunt D. Pathological gamblers in methadone treatment: a comparison between men and women. J Gambl Stud. 1996;12:431-449.
15. Linden RD, Pope HG, Jonas JM. Pathological gambling and major affective disorder: preliminary findings. J Clin Psychiatry. 1986;47:201-203.
16. McCormick RA, Russo AM, Ramirez LF, Taber JI. Affective disorders among pathological gamblers seeking treatment. Am J Psychiatry. 1984;141:215-218.
17. Ibanez A, Blanco C, Donahue E, et al. Psychiatric comorbidity in pathological gamblers seeking treatment. Am J Psychiatry. 2001;158:1733-1735.
18. Ladd GT, Petry NM. A comparison of pathological gamblers with and without substance abuse treatment histories. Exp Clin Psychopharmacol. 2003;11:202-209.
19. Maccallum F, Blaszczynski A. Pathological gambling and comorbid substance abuse. Aust N Z J Psychiatry. 2002;36:411-415.
20. Specker SM, Carlson GA, Edmonson KM, Johnson PE, Marcotte M. Psychopathology in pathological gamblers seeking treatment. J Gambl Stud. 1996;12:67-81.
21. Petry NM, Oncken C. Cigarette smoking is associated with increased severity of gambling problems in treatment-seeking gamblers. Addiction. 2002;97:745-753.
22. Stinchfield R, Winters K. Effectiveness of Six State-Supported Compulsive Gambling Treatment Programs in Minnesota. St. Paul: Compulsive Gambling Program, Mental Health Division, Minnesota Department of Human Services; 1996.
23. Hall GW, Carriero NJ, Takushi RY, Montoya ID, Preston KL, Gorelick DA. Pathological gambling among cocaine-dependent outpatients. Am J Psychiatry. 2000;157:1127-1133.
24. Steinberg MA, Kosten, TA, Rounsaville BJ. Cocaine abuse and pathological gamblers. Am J Addict. 1992;1:121-132.
25. Petry NM. Gambling problems in substance abusers are associated with increased sexual risk behaviors. Addiction. 2000;95:1089-1100.
26. McCormick RA. Disinhibition and negative affectivity in substance abusers with and without a gambling problem. Addict Behav. 1993;18:331-336.
27. Petry NM. Psychiatric symptoms in problem gambling and nonproblem gambling substance abusers. Am J Addict. 2000;9:163-171.
28. Daghestani AN, Elenz E, Crayton JW. Pathological gambling in hospitalized substance abusing veterans. J Clin Psychiatry. 1996;57:360-363.
29. Cho MJ, Hahm BJ, Suh T, Suh GH, Cho SJ, Lee CK. Comorbid mental disorders among the patients with alcohol abuse and dependence in Korea. J Korean Med Sci. 2002;17:236-241.
30. Rugle L, Melamed L. Neuropsychological assessment of attention problems in pathological gamblers. J Nerv Ment Dis. 1993;181:107-112.
31. Regard M, Knoch D, Gütling E, Landis T. Brain damage and addictive behavior: a neuropsychological and electroencephalogram investigation with pathologic gamblers. Cognitive and Behavioral Neurology and British Journal of Addiction. 2003;6:47-53.
32. Potenza MN, Leung HC, Blumberg HP, et al. An fMRI stroop task study of ventromedial prefrontal cortical function in pathological gamblers. Am J Psychiatry. 2003;160:1990-1994.
33. Petry NM. Substance abuse, pathological gambling, and impulsivity. Drug Alcohol Depend. 2001;63:29-38.
34. Cavedini P, Riboldi G, Keller R, D'Annucci A, Bellodi L. Frontal lobe dysfunction in pathological gambling patients. Biol Psychiatry. 2002;51:334-341.
35. Petry NM. Pathological gamblers, with and without substance use disorders, discount delayed rewards at high rates. J Abnorm Psychol. 2001;110:482-487.
36. Petry NM, Casarella T. Excessive discounting of delayed reinforcers in substance abusers with gambling problems. Drug Alcohol Depend. 1999;56:25-32.
37. Koob GF. Drug of abuse: anatomy, pharmacology and function of reward pathways. Trends Pharmacol Sci. 1992;13:177-184.
38. Roy A, Adinoff B, Roehrich L, et al. Pathological gambling: a psychobiological study. Arch Gen Psychiatry. 1988;45:369-373.
39. Bergh C, Eklund T, Sodersten P, Nordin C. Altered dopamine function in pathological gambling. Psychol Med. 1997;27:473-475.
40. Shinohara K, Yanagisawa A, Kagota Y, et al. Physiological changes in Pachinko players: beta-endorphin, catecholamines, immune system substances and heart rate. Appl Human Sci. 1999;18:37-42.
41. Blaszczynski AP, Wintor SW, McConaghy N. Plasma endorphin levels in pathological gambling. J Gambl Stud. 1986;2:3-14.
42. Oreland L, Ekblom J, Garpenstrand H, Hallman J. Biological markers, with special regard to platelet monoamine oxidase (trbc-MAO), for personality and personality disorders. Adv Pharmacol. 1998;42:301-304.
43. Moreno I, Sáiz-Ruiz J, López-Ibor JJ. Serotonin and gambling dependence. Hum Psychopharmacol. 1991;6:S9-S12.
44. Blanco C, Orensanz-Muñoz L, Blanco-Jerez C, Saiz-Ruiz J. Pathological gambling and platelet MAO activity: a psychobiological study. Am J Psychiatry. 1996;153:119-121.
45. Carrasco JL, Sáiz-Ruiz J, Hollander E, Cesar J, Lopez-Ibor JJ. Low platelet monoamine oxidase activity in pathological gambling. Acta Psychiatr Scand. 1994;90:427-431.
46. Nordin C, Eklundh T. Altered CSF 5-HIAA disposition in pathological male gamblers. CNS Spectr. 1999;4:25-33.
47. Roy A, Linnoila M. CSF studies on alcoholism and related behaviours. Prog Neuropsychopharmacol Biol Psychiatry. 1989;13:505-511.
48. Roy A, DeJong J, Linnoila M. Extraversion in pathological gamblers: correlates with indexes of noradrenergic function. Arch Gen Psychiatry. 1989;46:679-681.
49. Eisen SA, Lin N, Lyons MJ, et al. Familial influences on gambling behavior: an analysis of 3359 twin pairs. Addiction. 1998;93:1375-1384.
50. Slutske WS, Eisen S, True WR, et al. Common genetic vulnerability for pathological gambling and alcohol dependence in men. Arch Gen Psychiatry. 2000;57:666-673.
51. Comings DE, Rosenthal RJ, Lesieur HR, et al. A study of the dopamine D2 receptor gene in pathological gambling. Pharmacogenetics. 1996;6:223-234.
52. Blum K, Sheridan PJ, Wood RC, Braverman ER, Chen TJ, Comings DE. Dopamine D2 receptor gene variants: association and linkage studies in impulsive-addictive-compulsive behavior. Pharmacogenetics. 1995;5:121-141.
53. Comings DE, Gade R, Wu S, et al. Studies of the potential role of the dopamine D1 receptor gene in addictive behaviors. Mol Psychiatry. 1997;2:44-56.
54. Comings DE, Gonzalez N, Wu S, et al. Studies of the 48 bp repeat polymorphism of the DRD4 gene in impulsive, compulsive, addictive behaviors: Tourette syndrome, ADHD, pathological gambling, and substance abuse. Am J Med Genet. 1999;88:358-368.
55. Pérez de Castro I, Ibáñez A, Torres P, et al. Genetic association study between pathological gambling and a functional DNA polymorphism at the D4 receptor. Pharmacogenetics. 1997;7:345-348.
56. Ibañez A, de Castro IP, Fernández-Piqueras J, Blanco C, Saiz-Ruiz J. Genetic association study between pathological gambling and DNA polymorphic markers at MAO-A and MAO-B genes. Mol Psychiatry. 2000;5:105-109.
57. Comings DE, Gade-Andavolu R, Gonzalez N, et al. The additive effect of neurotransmitter genes in pathological gambling. Clin Genet. 2001;60:107-116.
58. Petry NM. A comparison of young, middle age, and older adult treatment-seeking pathological gamblers. The Gerontologist. 2002;42:92-99.
59. Muthén BO, Muthén LK. The development of heavy drinking and alcohol-related problems from ages 18 to 37 in a U.S. national sample. J Stud Alcohol. 2000;61:290-300.
60. Slutske WS, Jackson KM, Sher KJ. The natural history of problem gambling from age 18 to 29. J Abnorm Psychol. 2003;112:263-274.
61. Institute of Medicine. Broadening the Base of Treatment for Alcohol Problems. Washington, DC: National Academy of Sciences; 1990.
62. Hodgins DC, el-Guebaly N. Natural and treatment-assisted recovery from gambling problems: a comparison of resolved and active gamblers. Addiction. 2000;95:777-789.
63. Sobell LC, Cunningham JA, Sobell MB. Recovery from alcohol problems with and without treatment: prevalence in two population surveys. Am J Public Health. 1996;86:966-972.
64. Petry NM. Pathological Gambling: Etiology, Comorbidity, and Treatment. Washington, DC: American Psychological Association Press; 2005.
65. National Research Council. Pathological Gambling: A Critical Review. Washington, DC: National Academy Press; 1999.
66. Stewart RM, Brown RIF. An outcome study of Gamblers Anonymous. Br J Psychiatry. 1988;152:284-288.
67. Petry NM. Patterns and correlates of Gamblers Anonymous attendance in pathological gamblers seeking professional treatment. Addict Behav. 2003;27:1-14.
68. Chaney EF, O'Leary MR, Marlatt GA. Skill training with alcoholics. J Consult Clin Psychol. 1978;46:1092-1104.
69. McCormick RA. The importance of coping skill enhancement in the treatment of the pathological gambler. J Gambl Stud. 1994;10:77-86.
70. Marlatt, GA. Controlled drinking: the controversy rages on. Am Psychol. 1985;40:374-375.
71. Blaszczynski A, Silove D. Cognitive and behavioral therapies for pathological gambling. J Gambl Stud. 1995;11:195-220.
72. Lopez-Viets VC, Miller WR. Treatment approaches for pathological gamblers. Clin Psychology Rev. 1997;17:689-702.
73. Sharpe L. A reformulated cognitive-behavioral model of problem gambling: a biopsychosocial perspective. Clin Psychol Rev. 2002;22:1-25.
74. Echeburúa E, Baez C, Fernandez-Montalvo J. Comparative effectiveness of three therapeutic modalities in the psychological treatment of pathological gambling: long-term outcome. Behavioural and Cognitive Psychotherapy. 1996;24:51-72.
75. Echeburúa E, Fernandez-Montalvo J, Baez C. Predictors of therapeutic failure in slot-machine pathological gamblers following behavioural treatment. Behavioural and Cognitive Psychotherapy. 2001;29:379-383.
76. Petry NM, Ammerman Y, Bohl J, et al. Cognitive-behavioral therapy for pathological gamblers. J Consult Clin Psychol. 2006;74:555-567.
77. Petry NM, Litt MD, Kadden RM, Ledgerwood DM. Coping skills acquisition mediates the relationship between cognitive-behavioral therapy and treatment outcomes in pathological gamblers. In review.
78. Babor TF. Avoiding the horrid and beastly sin of drunkenness: does dissuasion make a difference? J Consult Clin Psychol. 1994;62:1127-1140.
79. Chick J, Ritson B, Connaughton J, Stewart A. Advice versus extended treatment for alcoholism: a controlled study. Br J Addict. 1998;83:159-170.
80. Dickerson MG, Hinchy J, England S. Minimal treatments and problem gamblers: a preliminary investigation. J Gambl Stud. 1990;6:87-102.
81. Robson E, Edwards J, Smith G, Colman I. Gambling decisions: an early intervention program for problem gamblers. J Gambl Stud. 2002;18:235-255.
82. Miller WR, Rollnick S. Motivational Interviewing: Preparing People to Change Addictive Behavior. New York: Guilford Press; 1992.
83. Hodgins DC, Currie SR, el-Guebaly N. Motivational enhancement and self-help treatments for problem gambling. J Consult Clin Psychol. 2001;69:50-57.
84. Freidenberg BM, Blanchard EB, Wulfert E, Malta LS. Changes in physiological arousal to gambling cues among participants in motivationally enhanced cognitive-behavior therapy for pathological gambling: a preliminary study. Appl Psychophysiol Biofeedback. 2002;27:251-260.
85. Wulfert E, Blanchard EB, Martell R. Conceptrualizing and treating pathological gambling: a motivationally enhanced cognitive behavioral approach. Cognitive and Behavioral Practice. 2003;10:61-72.
86. Petry NM. Stages of change in treatment-seeking pathological gamblers. J Consult Clin Psychol. 2005;73:312-322.
87. Prochaska JO, Velicer WF, Rossi JS, et al. Stages of change and decisional balance for 12 problem behaviors. Health Psychol. 1994;13:39-46.
88. Blanco C, Petkova E, Ibanez A, Saiz-Ruiz J. A pilot placebo-controlled study of fluvoxamine for pathological gambling. Ann Clin Psychiatry. 2002;14:9-15.
89. Grant JE, Kim SW, Potenza MN, et al. Paroxetine treatment of pathological gambling: a multi-centre randomized controlled trial. Int Clin Psychopharmacol. 2003;18:243-249.
90. Hollander E, DeCaria CM, Finkell JN, Begaz T, Wong CM, Cartwright C. A randomized double-blind fluvoxamine/placebo crossover trial in pathologic gambling. Biol Psychiatry. 2000;47:813-817.
91. Kim SW, Grant JE, Adson DE, Shin YC, Zaninelli R. A double-blind placebo-controlled study of the efficacy and safety of paroxetine in the treatment of pathological gambling. J Clin Psychiatry. 2002;63:501-507.
92. Saiz-Ruiz J, Blanco C, Iba~nez A, et al. Sertraline treatment of pathological gambling: a pilot study. J Clin Psychiatry. 2005;66:28-33.
93. Hollander E, Sood E, Pallantini S, et al. Does sustained-release lithium reduce impulsive gambling and affective instability versus placebo in pathological gamblers with bipolar spectrum disorders? Am J Psychiatry. 2005;162:137-145.
94. Pallanti S, Quercioli L, Sood E, Hollander E. Lithium and valproate treatment of pathological gambling: a randomized single-blind study. J Clin Psychiatry. 2002;63:559-564.
95. Kim SW, Grant JE, Adson DE, Shin YC. Double-blind naltrexone and placebo comparison study in the treatment of pathological gambling. Biol Psychiatry. 2001;49:914-921.
96. Toneatto T, Ladouceur R. Treatment of pathological gambling: a critical review of the literature. Psychol Addict Behav. 2003;17:284-292.
97. Zion MM, Tracy E, Abell N. Examining the relationship between spousal involvement in Gam-Anon and relapse behaviors in pathological gamblers. J Gambl Stud. 1991;7:117-131.
98. Hodgins DC, Peden N, Cassidy E. The association between comorbidity and outcome in pathological gambling: a prospective follow-up of recent quitters. J Gambl Stud. 2005;21:255-271.
99. Toneatto T, Skinner W, Dragonetti R. Patterns of substance use in treatment-seeking problem gamblers: impact on treatment outcomes. J Clin Psychol. 2002;58:853-859.
100. Blaszczynski A, Nower L. A pathways model of problem and pathological gambling. Addiction. 2002;97:487-499.
101. Baron E, Dickerson M. Alcohol consumption and self-control of gambling behavior. J Gambl Stud. 1999;15:3-16.
102. Kyngdon A, Dickerson M. An experimental study of the effect of prior alcohol consumption on a simulated gambling activity. Addiction. 1999;94:697-707.
103. Hodgins DC, Makarchuk K. Trusting problem gamblers: reliability and validity of self-reported gambling behavior. Psychol Addict Behav. 2003;17:244-248.
104. Petry NM. A comparison of treatment-seeking pathological gamblers based on preferred gambling activity. Addiction. 2003;98:645-655.
105. Blaszczynski A, McConaghy N, Frankova A. A comparison of relapsed and non-relapsed abstinent pathological gamblers following behavioural treatment. Brit J Addiction. 1991;86:1485-1489.
106. Ladouceur R. Controlled gambling for pathological gamblers. J Gambl Stud. 2005;21:49-57.
107. Slutske WS, Caspi A, Moffitt TE, Poulton R. Personality and problem gambling: a prospective study of a birth cohort of young adults. Arch Gen Psychiatry. 2005;62:769-775.